Endogenous depression
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
53
|
|
0.300 |
None |
1.000 |
1 |
|
2004 |
2004 |
Persistent atrial fibrillation
|
phenotype |
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases
|
Pathologic Function
|
156
|
|
0.300 |
None |
1.000 |
1 |
|
2018 |
2018 |
Drug toxicity
|
group |
Chemically-Induced Disorders
|
Injury or Poisoning
|
86
|
|
0.300 |
None |
1.000 |
1 |
|
2018 |
2018 |
Glucose Metabolism Disorders
|
group |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
32
|
|
0.300 |
None |
1.000 |
1 |
|
2018 |
2018 |
Paroxysmal atrial fibrillation
|
disease |
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases
|
Disease or Syndrome
|
226
|
8
|
0.300 |
None |
1.000 |
1 |
|
2018 |
2018 |
familial atrial fibrillation
|
phenotype |
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases
|
Pathologic Function
|
157
|
1
|
0.300 |
None |
1.000 |
1 |
|
2018 |
2018 |
Schizophreniform Disorders
|
group |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
20
|
1
|
0.300 |
None |
1.000 |
1 |
|
2004 |
2004 |
Depression, Bipolar
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
116
|
2
|
0.300 |
None |
1.000 |
1 |
|
2004 |
2004 |
Atrial Fibrillation
|
disease |
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases
|
Disease or Syndrome
|
939
|
584
|
0.300 |
None |
1.000 |
1 |
|
2018 |
2018 |
Adverse reaction to drug
|
group |
Chemically-Induced Disorders
|
Pathologic Function
|
87
|
|
0.300 |
None |
1.000 |
1 |
|
2018 |
2018 |
Depressive Syndrome
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
45
|
3
|
0.300 |
None |
1.000 |
1 |
|
2004 |
2004 |
Psychosis, Brief Reactive
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
14
|
|
0.300 |
None |
1.000 |
1 |
|
2004 |
2004 |
Schizoaffective Disorder
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
126
|
61
|
0.300 |
None |
1.000 |
1 |
|
2004 |
2004 |
Muscular Atrophy
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Pathologic Function
|
49
|
|
0.200 |
None |
1.000 |
1 |
|
2007 |
2007 |
Other cataract
|
disease |
Eye Diseases
|
Disease or Syndrome
|
32
|
|
0.200 |
None |
1.000 |
1 |
|
2003 |
2003 |
Diabetes Mellitus, Experimental
|
disease |
Nutritional and Metabolic Diseases; Endocrine System Diseases
|
Experimental Model of Disease
|
522
|
|
0.200 |
None |
1.000 |
1 |
|
2011 |
2011 |
CUI: |
C0013604 |
Disease: |
Edema
|
Edema
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Pathologic Function
|
126
|
1
|
0.200 |
None |
1.000 |
1 |
|
2009 |
2009 |
Malocclusion
|
disease |
Stomatognathic Diseases
|
Anatomical Abnormality
|
128
|
10
|
0.200 |
None |
1.000 |
1 |
|
2011 |
2011 |
Visual seizure
|
disease |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Disease or Syndrome
|
209
|
|
0.200 |
None |
1.000 |
1 |
|
2010 |
2010 |
Status Epilepticus
|
disease |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Disease or Syndrome
|
533
|
12
|
0.200 |
None |
1.000 |
1 |
|
2011 |
2011 |
Brain Ischemia
|
disease |
Nervous System Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
358
|
5
|
0.200 |
None |
1.000 |
1 |
|
2007 |
2007 |
Precocious Puberty
|
disease |
Endocrine System Diseases
|
Disease or Syndrome
|
139
|
20
|
0.110 |
None |
1.000 |
1 |
|
2018 |
2018 |
Serum HDL cholesterol measurement
|
phenotype |
|
Laboratory Procedure
|
283
|
679
|
0.100 |
None |
1.000 |
1 |
1
|
2012 |
2012 |
High density lipoprotein measurement
|
phenotype |
|
Laboratory Procedure
|
545
|
1440
|
0.100 |
None |
1.000 |
1 |
1
|
2012 |
2012 |
Carcinoma breast stage IV
|
disease |
|
Neoplastic Process
|
573
|
14
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |